3 structural-engineering-"https:"-"https:"-"https:"-"https:" positions at Center for Biologics Evaluation and Research (CBER)

FDA Computational and Experimental Assessment of Engineered Biotherapeutics: Safety and Regulatory Considerations of Synonymous Gene Recoding

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 19 hours ago

how synonymous sequence changes affect mRNA structure, translation kinetics, codon usage bias, ribosome dynamics, and protein folding trajectories. You will be able to leverage in silico platforms

FDA Evaluation and Characterization of Neutralizing Antibodies Against Viruses Relevant to Blood-Derived Products

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 19 hours ago

et al., Amino acid residue-specific neutralization and nonneutralization of hepatitis C virus by monoclonal antibodies to the E2 protein. J Virol 86, 12686-12694 (2012). 3. L. Deng et al., Structural

FDA Optimization Modeling to Support Benefit-Risk Assessment Fellowship

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 19 hours ago

mentor, you will apply novel technology to help develop a benefit-risk assessment modeling tool.  The activities include literature reviews, data collection/curation, model development, presentation